Literature DB >> 15820981

A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells.

Brian Albarran1, Richard To, Patrick S Stayton.   

Abstract

The HIV-1 TAT peptide has been used extensively for directing the intracellular delivery of an assortment of cargo, including DNA, liposomes and macromolecules. For protein delivery, a variety of TAT-fusion proteins have been described which link the TAT coding sequence to the protein coding sequence of interest. Streptavidin represents a potentially useful TAT-fusion protein because it could be used to deliver a wide array of biotinylated cargo. Here we have characterized a TAT-streptavidin (TAT-SA) fusion protein, which retains the ability to bind biotinylated cargo while directing their efficient cellular uptake. Fluorescence activated cell sorting (FACS) analysis and confocal microscopy characterization showed that TAT-SA is internalized by Jurkat T-cells and NIH 3T3 cells alone and when complexed to phycoerythrin, whereas the native streptavidin is not. Additionally, biotinylated alkaline phosphatase is successfully internalized and retains its activity when complexed to TAT-SA and incubated with Jurkat T-cells. Confocal microscopy suggested, however, that internalized TAT-SA and TAT-SA complexes were largely compartmentalized in vesicular compartments, rather than freely diffusing in the cytoplasmic compartment. To effect cytoplasmic delivery, the endosomal releasing polymer, poly(propylacrylic acid) (PPAA), was biotinylated and complexed to TAT-SA. Endosomal release and cytoplasmic delivery of fluorescently labeled TAT-SA complexes with PPAA was shown by the diffuse distribution of fluorescent protein in the cytoplasm. Taken together, these results demonstrate that TAT-SA can be used to direct intracellular delivery of large biotinylated cargo to intracellular compartments and that biotinylated PPAA can direct cytoplasmic delivery where desired.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15820981     DOI: 10.1093/protein/gzi014

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  16 in total

Review 1.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

2.  Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes.

Authors:  Amit A Kale; Vladimir P Torchilin
Journal:  J Drug Target       Date:  2007 Aug-Sep       Impact factor: 5.121

Review 3.  The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Authors:  Ashok Chauhan; Akshay Tikoo; Arvinder K Kapur; Mahavir Singh
Journal:  J Control Release       Date:  2006-11-17       Impact factor: 9.776

4.  Efficient Intracellular Delivery of a Pro-Apoptotic Peptide With A pH-Responsive Carrier.

Authors:  Brian Albarran; Allan S Hoffman; Patrick S Stayton
Journal:  React Funct Polym       Date:  2011-03-01       Impact factor: 3.975

5.  Slit diaphragm protein Neph1 and its signaling: a novel therapeutic target for protection of podocytes against glomerular injury.

Authors:  Ehtesham Arif; Yogendra S Rathore; Babita Kumari; Fnu Ashish; Hetty N Wong; Lawrence B Holzman; Deepak Nihalani
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

6.  Controlling mesenchymal stem cell gene expression using polymer-mediated delivery of siRNA.

Authors:  Danielle S W Benoit; Molly E Boutin
Journal:  Biomacromolecules       Date:  2012-10-11       Impact factor: 6.988

7.  Novel nanocomposites from spider silk-silica fusion (chimeric) proteins.

Authors:  Cheryl Wong Po Foo; Siddharth V Patwardhan; David J Belton; Brandon Kitchel; Daphne Anastasiades; Jia Huang; Rajesh R Naik; Carole C Perry; David L Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

8.  Intracellular delivery of a proapoptotic peptide via conjugation to a RAFT synthesized endosomolytic polymer.

Authors:  Craig L Duvall; Anthony J Convertine; Danielle S W Benoit; Allan S Hoffman; Patrick S Stayton
Journal:  Mol Pharm       Date:  2010-04-05       Impact factor: 4.939

9.  Non-covalent ligand conjugation to biotinylated DNA nanoparticles using TAT peptide genetically fused to monovalent streptavidin.

Authors:  Wenchao Sun; David Fletcher; Rolf Christiaan van Heeckeren; Pamela B Davis
Journal:  J Drug Target       Date:  2012-09       Impact factor: 5.121

10.  Antigen delivery with poly(propylacrylic acid) conjugation enhances MHC-1 presentation and T-cell activation.

Authors:  Suzanne Flanary; Allan S Hoffman; Patrick S Stayton
Journal:  Bioconjug Chem       Date:  2009-02       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.